The Kissenpfennig group


Dr Adrien Kissenpfennig

The Kissenpfennig group study key cells (skin dendritic cells) or molecules (SOCS proteins) to help further our understanding of inflammatory disease.   The research focuses on understanding cellular and signalling mechanisms that underlie pro- and anti-inflammatory processes to further the development of novel therapeutic strategies.   Understanding of these control mechanisms will underpin the development of novel drugs that harness these mechanisms to control inflammation and the development of cancer.

Current research programme includes:

  1. Understanding the importance of SOCS molecules in the polarization of immune cells.
  2. Identifying the contribution of skin DC subsets following transdermal vaccination.